Ratan Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Ratan Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$762K	Hold	1,550	–	–	0.28%	30
2025 Q4	$898K	Buy	1,550 +350	+29%	+$198K	0.25%	30
2025 Q3	$582K	Sell	1,200 -350	-23%	-$163K	0.31%	26
2025 Q2	$628K	Hold	1,550	–	–	0.29%	25
2025 Q1	$771K	Sell	1,550 -5,500	-78%	-$2.98M	0.25%	27
2024 Q4	$3.62M	Buy	7,050 +1,550	+28%	+$852K	0.56%	28
2024 Q3	$3.4M	Sell	5,500 -1,550	-22%	-$918K	0.92%	23
2024 Q2	$3.9M	Hold	7,050	–	–	1.18%	22
2024 Q1	$4.1M	Sell	7,050 -1,300	-16%	-$729K	2.18%	14
2023 Q4	$4.43M	Sell	8,350 -1,700	-17%	-$823K	2.89%	13
2023 Q3	$5.09M	Buy	10,050 +3,000	+43%	+$1.6M	3.85%	9
2023 Q2	$3.68M	Buy	7,050 +5,500	+355%	+$2.97M	5.09%	7
2023 Q1	$893K	Hold	1,550	–	–	2.37%	11
2022 Q4	$854K	Hold	1,550	–	–	0.59%	20
2022 Q3	$786K	Sell	1,550 -150	-9%	-$83.9K	1.86%	13
2022 Q2	$924K	Hold	1,700	–	–	0.78%	18
2022 Q1	$1M	Hold	1,700	–	–	0.7%	23
2021 Q4	$1.13M	Hold	1,700	–	–	0.17%	46
2021 Q3	$971K	Sell	1,700 -12,800	-88%	-$7.03M	0.13%	72
2021 Q2	$7.32M	Hold	14,500	–	–	0.63%	49
2021 Q1	$6.62M	Buy	14,500 +1,700	+13%	+$811K	0.73%	46
2020 Q4	$5.96M	Hold	12,800	–	–	0.7%	52
2020 Q3	$5.65M	Hold	12,800	–	–	0.83%	45
2020 Q2	$4.64M	Hold	12,800	–	–	1.55%	28
2020 Q1	$3.63M	Hold	12,800	–	–	1.69%	20
2019 Q4	$4.16M	Sell	12,800 -1,400	-10%	-$425K	2.52%	16
2019 Q3	$4.14M	Hold	14,200	–	–	2.19%	21
2019 Q2	$4.17M	Buy	+14,200	New	+$3.91M	0.93%	31

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ratan Capital Management's TMO Position: Q1 2026 in Review

Ratan Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 1,550 shares worth $762K. The position accounts for 0.28% of the portfolio, ranked #30.

Ratan Capital Management first reported a position in TMO in Q2 2019 and has held it in 28 quarters since. The position peaked at $7.32M in Q2 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Ratan Capital Management held 1,550 shares of Thermo Fisher Scientific worth $762K as of Q1 2026.
Ratan Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.28% of Ratan Capital Management's portfolio in Q1 2026, its #30 holding.
Ratan Capital Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 28 quarters since.
Ratan Capital Management's Thermo Fisher Scientific position peaked at $7.32M in Q2 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ratan Capital Management's 13F filing for Q1 2026, filed 14 May 2026.